<p>(A) KRAS mutation (G12V) identified by cycleave technology. (B) EGFR mutation (exon 19 deletion) identified by the fragment analysis (C) KRAS mutation (G12V) was detected with Ion PGM technology. C to A transversion was identified. (D) EGFR mutation (exon 19 deletion) was detected with Ion PGM technology.</p
<p>Comparison of the PNA-LNA PCR clamp with direct sequencing and Ion torrent PGM for detection of <...
<p>Detectability analysis of various mutant type-specific sensitive methods in an independent direct...
Background. KRAS genotyping in tumor samples is a decisive clinical test for the anti-EGFR therapy m...
<p>Different melting curves showing mutation type (red line) relative to wild type (grey line) of KR...
<p>EGFR mutations status detected by direct sequencing, PNA-LNA PCR clamp, and Ion Torrent PGM accom...
<p>A) Electropherogram obtained using Sanger sequencing. The <i>KRAS</i> G12D mutation is identified...
<p>A) Electropherogram obtained using Sanger sequencing. The mutation is not identified. B) Using AS...
Evidence that activating mutations of the KRAS oncogene abolish the response to anti-epidermal growt...
KRAS somatic mutations are found in 30\u201340% of colorectal cancer (CRC). Seven mutations in codon...
*<p>:The cases with both E19 (E746–A750) and E21 (L858R) mutations were not counted twice.</p><p>Oth...
Background: Mutations of the KRAS oncogene occur in a variety types of human tumors. By assessing th...
<p>Comparison of <i>KRAS</i> and <i>GNAS</i> mutations detected with targeted sequencing, exome sequ...
<p>(A) Cy5 fluorescence signal corresponding to the mutated allele. (B) spotting scheme. wt: wild-ty...
<p><b>A.</b> Mutation detection in the exons 9 and 20 of PIK3CA from NSCLC. The negative derivative ...
In Europe, the use of anti-EGFR monoclonal antibodies is restricted to Kirsten RAS (KRAS) wild-type ...
<p>Comparison of the PNA-LNA PCR clamp with direct sequencing and Ion torrent PGM for detection of <...
<p>Detectability analysis of various mutant type-specific sensitive methods in an independent direct...
Background. KRAS genotyping in tumor samples is a decisive clinical test for the anti-EGFR therapy m...
<p>Different melting curves showing mutation type (red line) relative to wild type (grey line) of KR...
<p>EGFR mutations status detected by direct sequencing, PNA-LNA PCR clamp, and Ion Torrent PGM accom...
<p>A) Electropherogram obtained using Sanger sequencing. The <i>KRAS</i> G12D mutation is identified...
<p>A) Electropherogram obtained using Sanger sequencing. The mutation is not identified. B) Using AS...
Evidence that activating mutations of the KRAS oncogene abolish the response to anti-epidermal growt...
KRAS somatic mutations are found in 30\u201340% of colorectal cancer (CRC). Seven mutations in codon...
*<p>:The cases with both E19 (E746–A750) and E21 (L858R) mutations were not counted twice.</p><p>Oth...
Background: Mutations of the KRAS oncogene occur in a variety types of human tumors. By assessing th...
<p>Comparison of <i>KRAS</i> and <i>GNAS</i> mutations detected with targeted sequencing, exome sequ...
<p>(A) Cy5 fluorescence signal corresponding to the mutated allele. (B) spotting scheme. wt: wild-ty...
<p><b>A.</b> Mutation detection in the exons 9 and 20 of PIK3CA from NSCLC. The negative derivative ...
In Europe, the use of anti-EGFR monoclonal antibodies is restricted to Kirsten RAS (KRAS) wild-type ...
<p>Comparison of the PNA-LNA PCR clamp with direct sequencing and Ion torrent PGM for detection of <...
<p>Detectability analysis of various mutant type-specific sensitive methods in an independent direct...
Background. KRAS genotyping in tumor samples is a decisive clinical test for the anti-EGFR therapy m...